
|Videos|March 27, 2017
The Long-Term Impact of Biosimilars
Author(s)Lauren Santye, Assistant Editor
Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses how biosimilars could impact specialty pharmacy into the immediate future.
Advertisement
Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses how biosimilars could impact specialty pharmacy into the immediate future.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Therapeutic Cancer Vaccines: Are We There Yet?
2
FDA Approves Gazyva for Active Lupus Nephritis
3
Walgreens Strengthens Vaccine Access Through Digital Tools, Pharmacist Education
4
In the Fragmented Landscape of Long COVID Care, Pharmacists Are Essential
5